COST-EFFECTIVENESS REVIEWS BY HTA AGENCIES: A COMPARISON OF FACTORS LEADING TO UNFAVOURABLE REVIEWS FOR ONCOLOGY AGENTS

被引：0
|
作者：
Smith, N. [1 ]
Beckerman, R. [1 ]
机构：
[1] CBPartners, New York, NY USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.048
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HT4
引用
收藏
页码：A7 / A7
页数：1
相关论文
共 50 条
  • [31] Evaluating the cost-effectiveness of population health interventions alongside literature reviews: the case of comprehensive geriatric assessment
    Tsiachristas, Apostolos
    Gardner, Mike
    Ellis, Graham
    Shepperd, Sasha
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2017, 17
  • [32] A COMPARISON OF OUTCOMES MEASURES IN COST-EFFECTIVENESS ANALYSIS: THREE APPLICATIONS WITHIN ONCOLOGY
    Reddy, B.
    Telford, C.
    Turko, A.
    Woodward, T. C.
    Ambavane, A.
    Mahajan, S.
    Caro, J. J.
    VALUE IN HEALTH, 2024, 27 (12) : S93 - S93
  • [33] A COMPARISON OF THREE AND FOUR STATE ECONOMIC MODELS FOR COST-EFFECTIVENESS ANALYSIS IN ONCOLOGY
    Incerti, D.
    Jansen, J. P.
    VALUE IN HEALTH, 2019, 22 : S40 - S41
  • [34] What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations
    Long, Linda
    Briscoe, Simon
    Cooper, Chris
    Hyde, Chris
    Crathorne, Louise
    HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (08) : 1 - +
  • [35] Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness
    Pickett, Karen
    Loveman, Emma
    Kalita, Neelam
    Frampton, Geoff K.
    Jones, Jeremy
    HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (86) : 1 - +
  • [36] Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report
    Mandrik, Olena
    Severens, J. L.
    Bardach, Ariel
    Ghabri, Salah
    Hamel, Candyce
    Mathes, Tim
    Vale, Luke
    Wisloff, Torbjorn
    Goldhaber-Fiebert, Jeremy D.
    VALUE IN HEALTH, 2021, 24 (04) : 463 - 472
  • [37] COST-EFFECTIVENESS COMPARISON ANALYSIS OF ANTI-TNF AGENTS WITH MULTIPLE INDICATIONS
    Szkurhan, A. R.
    VALUE IN HEALTH, 2009, 12 (03) : A133 - A133
  • [38] A COST-EFFECTIVENESS COMPARISON OF THE USE OF ANTIMICROBIAL AGENTS FOR TREATMENT OR PROPHYLAXIS OF TRAVELERS DIARRHEA
    REVES, RR
    JOHNSON, PC
    ERICSSON, CD
    DUPONT, HL
    ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (11) : 2421 - 2427
  • [39] COMPARISON OF METHODS TO ACCOUNT FOR CURED PATIENTS IN A COST-EFFECTIVENESS ANALYSIS: A CASE STUDY IN ONCOLOGY
    Colonier, Foix A.
    Genestier, V
    Lueza, B.
    VALUE IN HEALTH, 2019, 22 : S475 - S475
  • [40] EFFICIENCY-EQUITY TRADE-OFFS IN COST-EFFECTIVENESS ANALYSES: AN UMBRELLA REVIEW OF PREVIOUS SYSTEMATIC LITERATURE REVIEWS
    Radhakrishnan, A.
    Muir, J.
    Freitag, A.
    Ozer, Stillman, I
    Sarri, G.
    VALUE IN HEALTH, 2023, 26 (06) : S98 - S98
12345